Dr. Andrew Pecora, at the John Theurer Cancer Center campus, (part of Hackensack Meridian Health) in Hackensack New Jersey, worked collaboratively with other investigators on this and is available to speak about this to the media today. JTCC will also be part of the clinical III trials for this study. I’m happy to arrange a time for you to interview Dr. Pecora.
The John Theurer Cancer Center is participating in the phase III clinical trials as part of our ongoing research.
